Phase II Study of Single Agent Lenvatinib
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: lenvatinib
Sponsor: National University Hospital, Singapore
Collaborators: Eisai Co., Ltd.|Tan Tock Seng Hospital